Literature DB >> 4016008

Modified nucleosides in asbestos workers at high risk of malignant disease: results of a preliminary study applying discriminant analysis.

S J Solomon, A Fischbein, O K Sharma, E Borek.   

Abstract

Patients with asbestos related malignant mesothelioma excrete high levels of modified nucleosides in their urine. The purpose of the present report was to explore further the usefulness of measuring these breakdown products of transfer RNA (tRNA) in male asbestos insulation workers who are at high neoplastic risk but without clinical signs of malignancy. Modified nucleoside levels (psi, m'A, m'I, m2G, and ac4C) were used as discriminator variables in a computer generated discriminant function in which 96% of the controls and 95% of the insulation workers were correctly classified. It was also found, using a similar multiple regression model, that 10 of 13 were correctly classified as having normal chest radiographs and 27 of 30 asbestos exposed subjects as exhibiting alterations in either the parenchyma, pleura, or both. The results suggest that measuring modified nucleosides levels in the urine of asbestos exposed workers, and perhaps others exposed to carcinogenic agents, has the potential for identifying, through multivariate statistical techniques, individuals who are at high neoplastic risk.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4016008      PMCID: PMC1007528          DOI: 10.1136/oem.42.8.560

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  7 in total

1.  High turnover rate of transfer RNA in tumor tissue.

Authors:  E Borek; B S Baliga; C W Gehrke; C W Kuo; S Belman; W Troll; T P Waalkes
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

2.  Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase, and modified nucleosides as biological markers in malignant lymphomas.

Authors:  T Rasmuson; G R Björk; L Damber; S E Holm; L Jacobsson; A Jeppsson; B Littbrand; T Stigbrand; G Westman
Journal:  Recent Results Cancer Res       Date:  1983

3.  Applications of urinary nucleosides in cancer diagnosis and cancer management.

Authors:  O K Sharma; T P Waalkes; C W Gehrke; E Borek
Journal:  Cancer Detect Prev       Date:  1983

4.  Quantitative high-performance liquid chromatography of nucleosides in biological materials.

Authors:  C W Gehrke; K C Kuo; G E Davis; R D Suits; T P Waalkes; E Borek
Journal:  J Chromatogr       Date:  1978-03-21

5.  Urinary excretion of modified nucleosides in patients with malignant mesothelioma.

Authors:  A Fischbein; O K Sharma; I J Selikoff; E Borek
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

6.  Transfer RNA breakdown products in the urine of asbestos workers.

Authors:  A Fischbein; O K Sharma; S Solomon; F Buschman; G Apell; M Kohn; I J Selikoff; J G Bekesi; E Borek
Journal:  Cancer Detect Prev       Date:  1984

7.  Patterns of urinary excretion of modified nucleosides.

Authors:  C W Gehrke; K C Kuo; T P Waalkes; E Borek
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.